Skip to content

Dose-response-relationship of Isomaltulose

Dose-response-relationship of Isomaltulose - ISOMALT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00021140
Enrollment
12
Registered
2020-03-26
Start date
2019-12-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

Group 1: Intervention group with different concentrations of isomaltulose. The concentrations were 0 g/h, 20 g/h, 40 g/h, and 60 g/h. Isomaltulose powder will be used which was acquired from Peeroton

Sponsors

Universität Wien
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: men aged between 18 and 40 years motivation for participating in scientific work cycling training since 3 years or more

Exclusion criteria

Exclusion criteria: injury prior or during the study cardiovascular, pulmonary or metabolic diseases acute infection 1 week prior first test or during testing autoimmune disease or diseases of the immune system intake of substances banned by WADA-code in training or competition or that have the potential to influence measurement intolerance of isomaltulose, glucose, fructose, and/or maltodextrin age 40 years

Design outcomes

Primary

MeasureTime frame
Dose-response-relationship of isomaltulose during a 15-min time-trial after a fatiguing exercise. Subjects will perform a self-paced time-trial on a cycle ergometer. They are required to produce the highest average power output possible.

Secondary

MeasureTime frame
Assessment of several physiological parameters that are associated with the development of fatigue. During the 2-h constant work loads oxygen uptake, carbon dioxide output, minute ventilation, and blood lactate concentration will be assessed.

Countries

Austria

Contacts

Public ContactChristoph Triska

Universität Wien

christoph.triska@univie.ac.at+431427748867

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026